Patent · US Active

2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10

US8586748B2 · kind B2 · utility

1Cited by

1References

5Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Asitha Abeywardane · Danbury, US
Derek Cogan · Sandy Hook, US
Younggi Choi · Stow, US
Donghong Amy Gao · Hopewell Junction, US
Daniel R. Goldberg · Redding, US
Alexander Heim-Riether · Ingelheim am Rhein, DE
Craig Andrew Miller · Penfield, US
Philip Dean Ramsden · Cambridge, US
Lana Louise Smith Keenan · Poughquag, US
Roger John Snow · Danbury, US
Yang Yu · Jinan, CN

Key dates

Filing date	Apr 8, 2009
Grant date	Nov 19, 2013
Priority date	—
Expiry date	Dec 2, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein R1, R2, R4. Ar and Het are as defined herein. The invention also relates to methods of using the compound of formula (I) to treat a diseases and disorders that are mediated or sustained through the activity of CCR10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.